Improved respiratory pathology associated to Pompe disease with the new vector AAV-B1-GAA May 16, 2017
Exscientia and Sanofi enter agreement on bispecific small-molecule drugs for metabolic disease May 9, 2017
TherapeuticsMD receives complete response letter from FDA for TX-004HR as treatment of dyspareunia May 9, 2017